We generated stable knockout of STK25 in HepG2 (human hepatoblastoma cells) utilizing CRISPR/Cas9 technology and injected these cells subcutaneously into the flanks of high-fat diet-fed BALB/c nude mice (Figure 3A–B). The gene discussed is STK25; the disease is hepatoblastoma.